Lv1
12 积分 2022-03-02 加入
Long-term Results of Intrapericardial Chemotherapeutic Treatment of Malignant Pericardial Effusions With Thiotepa
14天前
已完结
Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome
14天前
已完结
Current and emerging strategies for management of myelodysplastic syndromes
19天前
已完结
Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors
19天前
已完结
Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents
20天前
已完结
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
26天前
已关闭
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study
1个月前
已完结
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study
1个月前
已完结
The bone-marrow niche in MDS and MGUS: implications for AML and MM
1个月前
已完结
皖公网安备34019202002308
